Concepedia

David P. Friedland

DP

Statistics

Publications

4

Citations

204

H-Index

4

Active since

1999

Affiliations

Sidney Kimmel Cancer Center(Current)

Allegheny General Hospital

David P. Friedland is an author at Sidney Kimmel Cancer Center specializing in oncology, cancer therapeutics, and medicine.

Top concepts

Publications per year

1999–2006

4

Publications

4

Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c-<i>raf</i>-1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A)

James Stevenson, Kang-Shen Yao, Maryann Gallagher et al. · Journal of Clinical Oncology · 1999 · 130 citations

Phase II: Trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy

Maria Werner‐Wasik, Rita Axelrod, David P. Friedland et al. · Seminars in Radiation Oncology · 2002 · 28 citations

, , +8

A Phase II Study of Weekly Paclitaxel/Estramustine/Carboplatin in Hormone-Refractory Prostate Cancer

William R. Berry, David P. Friedland, John Fleagle et al. · Clinical Genitourinary Cancer · 2006 · 27 citations

, , +7

Preliminary Report on Reduction of Esophagitis by Amifostine in Patients with Non–Small-Cell Lung Cancer Treated with Chemoradiotherapy

Maria Werner‐Wasik, Rita Axelrod, David P. Friedland et al. · Clinical Lung Cancer · 2001 · 19 citations

, , +7

Rows per page

1–4 of 4